Is a new Covid therapy based on monoclonal antibodies soon to be reviewed? This is what infectious disease specialist and member of Spiklmm biotech administration board Karine Lacombe has explained. The very laboratory is developing this therapy. Clinical trials are expected to start from the beginning of 2022.
This morning on France Inter, infectious disease specialist Karine Lacombe claims that because of the high contagiousness of the Delta variant, “in France, whether one will be vaccinated, or one will have been sick”.
As many French people are eager to return to terraces and some cultural places starting from May 19, infectious disease specialist Karine Lacombe thinks – in an interview with BFMTV this Thursday May 6, 2021 – the summer “can become a nightmare”.
Even though so far, no Indian variant case has been detected in the country, “it’s a matter of days”, infectious disease specialist Karine Lacombe said this April 21 on France Info, adding “the Indian variant will arrive in France”.
